GASTRO-ULC - for Gastrointestinal
Support
1 Bottle - 90 tablets
Herbs and amino acids for
support of the stomach and intestinal lining. Providing natural relief from stomach acidity without stopping digestion.
Provides compounds with naturally-occuring antibacterial properties that help re-establish healthy gastrointestinal
terrain, and is especially supportive during Heliobacter pylori activity. (Use in conjuction with H-PLR.)
The compounds in Gastro-ULC
have shown the ability to increase the number of villi and cells of the small intestine, manage gastric gastric inflammation, increase mucous formation, and maintain healthy gastric lining.
Dosage: Take 2 capsules 3x day with meals and additional times
as needed.
Note: Often used with H-PLR
if possible infection is suspected.
Ingredients:
Deglycyrrhizinated Licorice
root (DGL) 300 mg
L-Glutamine 200 mg
Mastic gum 150 mg
Citrus Bioflavonoids 100 mg
Bismuth citrate 75 mg
Gamma Oryzanol 75 mg
Chlorella 50 mg
Rhubarb root 50 mg
Bentonite Clay 50 mg
RESEARCH:
GLUTAMINE
Glutamine is the preferred fuel source for the cells of the small intestine, and has been shown to be helpful in
the regeneration and repair of the intestinal lining. It has demonstrated the ability to increase the number of
cells in the small intestine, the number of villi on those cells, as well as the height of the villi. Glutamine
also reduces permeability of the lining that may accompany “leaky gut”
patterns and lead to inflammation or the development of delayed food intolerances.5 6 7
FLAVONOIDS (CATECHIN)
The flavonoid catechin has demonstrated properties that inhbit the enzyme histadine decarboxylase, thereby supporting
anti-ulcer activity. Several studies have demonstrated the positive impacts of catechin on ulcerative states.8 9 Flavonoids such as catechin have also been shown to inhibt H. pylori in a clear-cut
concentration-dependent manner.10
BISMUTH CITRATE
Bismuth is a naturally-occurring mineral that exhibits activity against H. pylori and is used in the treatment
of ulcers. Two double-blind placebo-controlled studies have demonstrated the safe and effective use of bismuth
in managing gastric inflammation.11
12
GAMMA-ORYZANOL
Gamma-Oryzanol is an ester of ferulic acid that is isolated from rice bran oil. It has been demonstrated as a powerful
antioxidant in experimental studies.13 14 Gamma-Oryzanol has proven effective in numerous gastrointestinal disorders
including ulcers, irritable bowel syndrome, gastritis, and even non-specific gastrointestinal conditions. In addition
to having an anti-inflammatory impact, it also seems to have normalization properties over the gastrointestinal
nervous system.15 16 17
5 Klimberg V, et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer July1;66(1):62-68,
1990.
6 Noyar CM, et al. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability
in patients with AIDS. Am J Gastroenterol 93(6), 972-975, 1998.
7 Evans MA and Shronts EP. Intestinal fuels: glutamine, short-chain fatty acids, and dietary fiber. J Amer Diet
Assoc 92, 1239-1246,1992.
8 Parmar N Ghosh M. Gastric
anti-ulcer activity of (+)-cyanidanol-3, a histdine decarboxylase inhibitor. Eur J Pharmacol 1981;69: 25-32.
9 Wendt P, Reiman H, et al. The use of flavonoids as inhibitors of histidine decarboxylase in gastric diseases.
Experimental and clinical studies. Naunyn-Schmiedeberg’s Arch Pharma (Supplement) 1980;313:238.
10 Beil W, Birkholz, Sewing KF. Effects of flavonoids on parietal cell acid secretion, gastric mucosal prostaglandin
production and Helicobacter pylori growth. Arzeneim Forsch 1995;45:697-700.
11Kang Jy, et al. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia.
A double blind placebo controlled study. Gut 1990;31: 476-480.
12 Marshall BJ, Valenzuela
JE, McCallum RW. Bismuth subsalicylate suppression of Helicobacteria pylori in non-ulcer dyspepsia. A double blind
placebo controlled trial. Dig Dis Sci 1993; 38:1674-1680.
15 Takemoto T, et al. Clinical trial of Hi-Z pills on gastrointestinal symptoms at 375 hospitals. Shiyaku To Rinsho
26, 2-27, 1977
16 Sasagwa T, et al. Clinical studies on gamma-oryzanol in the treatment of gastro-enero neurosis. Basic Pharmacol
Ther 4, 588-591,1980.
17 Minakuchi C, et al. Clinical effects of gamma-oryzanol on gastric system complaints.
Shiyaka To Rhinsho 25, 29-33,1976.
To Gallbladder
Product Kits >
To Individual
Gallbladder Products >
Not sure of what to order? Click
here for information about a consultation > |
|
| |
untitled
©Copryright 2007 GallbladderAttack.com.
All Rights Reserved.
Site Design by Surf4 Design Group.
Hosted by Surf4.net
|
|
Privacy Policy
Returns and
Cancellations
|
|
Deborah Graefer
GallbladderAttack.com
375 Stewart Rd
Wilkes-Barre, PA 18706
760-632-8089
|
|